“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
The Warren Buffett investment philosophy calls for a long-term investment horizon, where a five year holding period, or even longer, would fit right into the strategy. How would such a strategy have worked out for an investment into Regeneron Pharmaceuticals, Inc. (NASD: REGN)? Today, we examine the outcome of a five year investment into the stock back in 2014.
| Start date: | 07/24/2014 |
|
|||
| End date: | 07/23/2019 | ||||
| Start price/share: | $304.44 | ||||
| End price/share: | $309.26 | ||||
| Starting shares: | 32.85 | ||||
| Ending shares: | 32.85 | ||||
| Dividends reinvested/share: | $0.00 | ||||
| Total return: | 1.58% | ||||
| Average annual return: | 0.31% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $10,155.96 | ||||
As we can see, the five year investment result worked out as follows, with an annualized rate of return of 0.31%. This would have turned a $10K investment made 5 years ago into $10,155.96 today (as of 07/23/2019). On a total return basis, that’s a result of 1.58% (something to think about: how might REGN shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
One more investment quote to leave you with:
“I believe in the discipline of mastering the best that other people have ever figured out. I don’t believe in just sitting down and trying to dream it all up yourself. Nobody’s that smart.” — Charlie Munger
